| Schedule of calculation of basic and diluted net loss per share |
As the Company uses the two-class method required for companies with multiple classes of common stock, the following tables present the calculation of basic and diluted net loss per share for each class of the Company’s common stock outstanding (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | Three months ended March 31, 2025 | | | | | | | Class A | | Class B | | Total
Common Stock | | Numerator: | | | | | | | Allocation of undistributed earnings | $ | (12,396) | | | $ | (1,571) | | | $ | (13,967) | | | Numerator for basic and diluted net loss per share – loss available to common stockholders | $ | (12,396) | | | $ | (1,571) | | | $ | (13,967) | | | Denominator: | | | | | | | Weighted-average common shares outstanding | 208,496,599 | | 26,426,937 | | 234,923,536 | | Denominator for basic and diluted net loss per share – weighted-average common stock | 208,496,599 | | 26,426,937 | | 234,923,536 | | Basic and diluted net loss per share | $ | (0.06) | | | $ | (0.06) | | | $ | (0.06) | |
| | | | | | | | | | | | | | | | | | | Three months ended March 31, 2024 | | | | | | | Class A | | Class B | | Total
Common Stock | | Numerator: | | | | | | | Allocation of undistributed earnings | $ | (19,008) | | | $ | (2,753) | | | $ | (21,761) | | | Numerator for basic and diluted net loss per share – loss available to common stockholders | $ | (19,008) | | | $ | (2,753) | | | $ | (21,761) | | | Denominator: | | | | | | | Weighted-average common shares outstanding | 182,446,512 | | 26,426,937 | | 208,873,449 | | Denominator for basic and diluted net loss per share – weighted-average common stock | 182,446,512 | | 26,426,937 | | 208,873,449 | | Basic and diluted net loss per share | $ | (0.10) | | | $ | (0.10) | | | $ | (0.10) | |
|
| Schedule of anti-dilutive common equivalent shares |
The following table summarizes the Company’s anti-dilutive common equivalent shares: | | | | | | | | | | | | | March 31, | | 2025 | | 2024 | | Outstanding options to purchase common stock | 6,265,978 | | 7,151,158 | | Outstanding restricted stock units | 23,238,345 | | 22,972,497 | Outstanding employee stock purchase plan options | 3,176,285 | | — | | Outstanding warrants | 20,652,690 | | 20,652,690 | | Total anti-dilutive common equivalent shares | 53,333,298 | | 50,776,345 |
|